For the year ending 2025-12-31, NBIX made $2,860,500K in revenue. $485,900K in net income. Net profit margin of 16.99%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Total revenues | 2,860,500 | |||
| Cost of revenues | 52,100 | |||
| Research and development | 1,015,700 | |||
| Acquired in-process research and development | 17,400 | |||
| Selling, general, and administrative | 1,156,200 | |||
| Total operating expenses | 2,241,400 | |||
| Operating income | 619,100 | |||
| Unrealized (loss) gain on equity investments | -4,000 | |||
| Charges associated with convertible senior notes | 0 | |||
| Investment income and other, net | 90,300 | |||
| Total other income (expense), net | 86,300 | |||
| Income before provision for income taxes | 705,400 | |||
| Provision for income taxes | 226,800 | |||
| Net income | 478,600 | |||
| Foreign currency translation adjustments, net of tax | -3,800 | |||
| Unrealized gain (loss) on available-for-sale debt securities, net of tax | 3,500 | |||
| Comprehensive income | 485,900 | |||
| Earnings per share, basic (in usd per share) | 4.81 | |||
| Earnings per share, diluted (in usd per share) | 4.67 | |||
| Weighted average common shares outstanding, basic (in shares) | 99,500,000 | |||
| Weighted average common shares outstanding, diluted (in shares) | 102,500,000 | |||
NEUROCRINE BIOSCIENCES INC (NBIX)
NEUROCRINE BIOSCIENCES INC (NBIX)